Straits Times Index
3,310.28 +10.28 (+0.31%) Nikkei
38,585.70 -47.32 (-0.12%) Hang Seng
18,074.11 -261.21 (-1.42%) FTSE 100
8,272.46 +67.35 (+0.82%) Bitcoin USD
64,595.67 -871.75 (-1.33%) CMC Crypto 200
1,353.71 -6.62 (-0.49%)
TMCI Sep 2024 7.500 call
| Previous close | 0.5500 |
| Open | 0.5500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 7.50 |
| Expiry date | 2024-09-20 |
| Day's range | 0.5500 - 0.5500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
GlobeNewswireTreace to Present at Truist Securities MedTech Conference
Tuesday, June 18, 2024 at 8:00 am Eastern TimePONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside
GuruFocus.comDirector Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI)
On May 14, 2024, Director Jane Kiernan purchased 19,356 shares of Treace Medical Concepts Inc (NASDAQ:TMCI), as reported in the SEC Filing.
GuruFocus.comDirector Deepti Jain Acquires 25,000 Shares of Treace Medical Concepts Inc (TMCI)
On May 10, 2024, Deepti Jain, Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 25,000 shares of the company, as reported in a recent SEC Filing.
